SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001178913-22-004233
Filing Date
2022-12-05
Accepted
2022-12-05 06:16:14
Documents
2
Group Members
I.B.F MANAGEMENT LTD.ISRAEL BIOTECH FUND GP PARTNERS II, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G zk2228838.htm SC 13G 70456
2 EXHIBIT 1.1 exhibit_1-1.htm EX-99 6646
  Complete submission text file 0001178913-22-004233.txt   78605
Mailing Address 42 HAYARKON STREET YAVNE L3 8122745
Business Address 42 HAYARKON STREET YAVNE L3 8122745 97289324010
MediWound Ltd. (Subject) CIK: 0001593984 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88069 | Film No.: 221443699
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address PEKERIS 3 REHOVOT L3 670203
Business Address PEKERIS 3 REHOVOT L3 670203 972-72-251-4175
Israel Biotech Fund II, L.P. (Filed by) CIK: 0001782947 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G